G Storm Selected Research

G Storm Research Topics

Disease

17	Neoplasms (Cancer) 10/2021 - 01/2000
11	Infections 03/2012 - 04/2000
8	Inflammation (Inflammations) 03/2012 - 04/2000
6	Pneumonia (Pneumonitis) 07/2001 - 04/2000
5	Arthritis (Polyarthritis) 09/2011 - 04/2000
4	Carcinoma (Carcinomatosis) 09/2008 - 01/2000
3	Bacterial Infections (Bacterial Infection) 09/2018 - 06/2001
2	Melanoma (Melanoma, Malignant) 11/2012 - 10/2008
2	Fibrosis (Cirrhosis) 02/2012 - 12/2008
2	Colitis 09/2011 - 04/2000
2	Focal Infection 08/2001 - 04/2000
2	Staphylococcal Infections 08/2001 - 05/2000
1	Port-Wine Stain (Nevus Flammeus) 07/2019
1	Ureteral Obstruction 02/2012
1	Experimental Arthritis 09/2011
1	Crohn Disease (Crohn's Disease) 09/2011
1	Multiple Sclerosis 09/2011
1	Glioblastoma (Glioblastoma Multiforme) 02/2002
1	Anaphylaxis (Anaphylactic Shock) 02/2002
1	Hypersensitivity (Allergy) 02/2002
1	Human Influenza (Influenza) 11/2001
1	Liver Abscess 08/2001
1	Communicable Diseases (Infectious Diseases) 02/2001
1	Flushing 01/2001
1	Synovitis 09/2000
1	Rheumatoid Arthritis 09/2000
1	Pathologic Processes 09/2000
1	Escherichia coli Infections 06/2000

Drug/Important Bio-Agent (IBA)

25	Liposomes (Liposome)IBA 10/2021 - 01/2000
7	Pharmaceutical PreparationsIBA 09/2018 - 02/2001
3	Anti-Bacterial Agents (Antibiotics)IBA 09/2018 - 07/2001
3	Gentamicins (Gentamicin)FDA LinkGeneric 07/2001 - 02/2001
2	Imatinib Mesylate (Gleevec)FDA Link 03/2015 - 02/2012
2	MicellesIBA 11/2012 - 02/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2012 - 09/2011
2	arginyl-glycyl-aspartic acidIBA 06/2012 - 03/2003
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2011 - 09/2008
2	prednisolone phosphate FDA LinkGeneric 09/2011 - 04/2004
2	GlucocorticoidsIBA 09/2011 - 04/2004
2	liposomal doxorubicin (Doxil)FDA Link 02/2002 - 02/2002
2	AminoglycosidesIBA 09/2001 - 02/2001
2	LipidsIBA 06/2001 - 09/2000
2	2-(dimethylamino)ethyl methacrylateIBA 06/2001 - 01/2000
2	Interferon-gamma (Interferon, gamma)IBA 02/2001 - 01/2000
2	CytokinesIBA 02/2001 - 01/2000
2	VaccinesIBA 02/2001 - 01/2000
2	RadiopharmaceuticalsIBA 02/2001 - 05/2000
1	PolymersIBA 11/2012
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2012
1	LigandsIBA 06/2012
1	DNA (Deoxyribonucleic Acid)IBA 06/2012
1	IntegrinsIBA 06/2012
1	Small Interfering RNA (siRNA)IBA 06/2012
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 06/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2012
1	Muramidase (Lysozyme)IBA 02/2012
1	EnzymesIBA 12/2011
1	AnthracyclinesIBA 12/2011
1	ProdrugsIBA 12/2011
1	Antineoplastic Agents (Antineoplastics)IBA 12/2011
1	GlucuronidaseIBA 12/2011
1	dexamethasone 21-phosphate FDA LinkGeneric 09/2011
1	AntigensIBA 09/2011
1	Peptide Hydrolases (Proteases)FDA Link 09/2011
1	Therapeutic UsesIBA 09/2011
1	ErbB Receptors (EGF Receptor)IBA 09/2009
1	Monoclonal AntibodiesIBA 09/2009
1	Tyrosine Kinase InhibitorsIBA 09/2009
1	Insulin (Novolin)FDA Link 09/2009
1	Phosphotransferases (Kinase)IBA 12/2008
1	N-acetylcochinol-O-phosphateIBA 10/2008
1	Gemcitabine FDA Link 09/2008
1	hydroxypropyl methacrylateIBA 09/2008
1	N-(2-hydroxypropyl)methacrylamideIBA 09/2008
1	Collagen Type II (Type II Collagen)IBA 04/2004
1	Peptides (Polypeptides)IBA 03/2003
1	dioleoyl-N-(monomethoxypolyethylene glycol succinyl)phosphatidylethanolamineIBA 02/2002
1	VirosomesIBA 11/2001
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 08/2001
1	Ceftazidime (Fortum)FDA LinkGeneric 07/2001
1	polyanionsIBA 06/2001
1	Hyaluronic Acid (Hyaluronan)IBA 06/2001
1	Immunoglobulin Fab FragmentsIBA 06/2001
1	Drug CarriersIBA 02/2001
1	Proteins (Proteins, Gene)FDA Link 09/2000
1	PhosphatidylserinesIBA 09/2000
1	Ethylene Glycol (Monoethylene Glycol)IBA 09/2000
1	Clodronic Acid (Clodronate)IBA 09/2000
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 09/2000
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 09/2000
1	Immunoglobulin G (IgG)IBA 05/2000
1	Biotin (Vitamin H)FDA Link 05/2000
1	Superoxide DismutaseIBA 05/2000

Therapy/Procedure

4	Therapeutics 11/2012 - 09/2009
2	Aftercare (After-Treatment) 09/2011 - 04/2004
2	Intravenous Administration 02/2010 - 01/2004
1	Dye Lasers 07/2019
1	Microspheres (Microsphere) 03/2015
1	Injections 12/2011
1	Chemoradiotherapy 09/2008